Dr Amanda Farley is an Associate Professor in Public Health and Epidemiology working in the Department of Applied Health Sciences. She has 20 years’ experience of research within the field of public health and teaches epidemiology and research methods on the masters in public health (MPH), undergraduate medical sciences (BMedSc) and undergraduate medicine degree (MBChB) programmes. Amanda is Head of Post Graduate Research (PGR) for the Department of Applied Health Sciences overseeing PhD, MD and MSc by research programmes within the department.

Amanda’s research interests centre on the development/ testing of interventions to support people to change behaviours that harm health, and quantification of the effects of behaviour change. In particular, she has significant expertise and track record in the field of tobacco addiction.  Amanda is experienced in conducting systematic reviews, feasibility and full-scale trials and has been lead/co-applicant of funding awarded from the NIHR, MRC and CRUK for work within these fields.

Melanie Böckmann is professor of Global Health at the University of Bremen in Germany. Her tobacco-focused research interests lie with implementation research, smokeless tobacco, and tobacco use in tuberculosis patients, predominantly in South Asia and using qualitative methods. She has previously served as SRNT University Innovations Director, volunteered with the SRNT Health Equity Network, and is collaborating with colleagues in the UK, Nepal, Bangladesh, Pakistan and Japan.

Prof Sarah Jackson is a Professorial Research Fellow in the UCL Alcohol and Tobacco Research Group. Her work focuses on monitoring population trends in smoking, vaping, and alcohol use and evaluating the effectiveness of smoking cessation aids, interventions, and policies at the individual and population level. To do this, she makes use of large, population-based datasets such as the Smoking and Alcohol Toolkit Study. She has authored over 200 peer-reviewed publications relating to nicotine and tobacco, alcohol, and other health-related issues such as obesity and cancer. She has also contributed to influential reports on smoking, vaping, and health by the Royal College of Physicians' Tobacco Advisory Group. The contribution of her work has been recognised by several awards, including the Society for the Study of Addiction (SSA)'s Impact Prize and early career awards from the SSA (Fred Yates Prize) and UK Society for Behavioural Medicine.

Stephanie Klosterhalfen is a post-doctoral researcher at the Institute of General Practice at Heinrich Heine University Düsseldorf. She holds an M.Sc. in Health Economics and a Doctorate in Public Health. With several years of experience in nicotine and tobacco research, she coordinates the German Study on Tobacco Use (DEBRA), a nationwide survey on smoking behaviour in Germany. Her research focuses particularly on shisha consumption, with a special interest in its use among adolescents and young adults.

Dr Catherine Kimber is a senior lecturer and lead of the Nicotine, Tobacco and Vaping research group at London South Bank University (LSBU), London, UK. She is an active researcher with over 10 years’ experience of working in the tobacco control and a track record of publishing high-quality peer-reviewed outputs. Her work includes experimental work to measure puffing topographies, nicotine delivery and absorption, public health messaging on harms related to vaping, and optimising smoking cessation interventions which include e-cigarettes. Her early work focused on exploring the theory of nicotine-titration and compensatory behaviours in vapers and suggested that when switching to lower nicotine concentrations, vapers will change their puffing to compensate for the drop in nicotine thereby potentially increasing their exposure to toxicants. Findings from this research programme were replicated in later studies (in-lab and in a real-world settings), contributing to new body of knowledge around compensatory behaviours in vapers, and furthering the understanding of the health and cost implications of limiting nicotine concentrations in e-liquid. Other areas of her work have focused on health warning labels for e-cigarette product packages, i.e. designing alternative labels that contextualize vaping’s risks to promote harm reduction and correct misperceptions. Her most recent work has focused on developing and optimising digital smoking cessation interventions that incorporate e-cigarettes. Catherine has secured and delivered several funded projects as Principal Investigator and lead researcher, including funding from CRUK and the Medical Research Council (MRC). 

Floor van den Brand is assistant professor at the Department of Family Medicine at Maastricht University. Her research interest lies in behavioral and policy interventions for stimulating smoking cessation in individuals with a lower socioeconomic position. She conducts research on implementing smoking cessation group trainings with financial incentives targeting people with a lower socioeconomic position and is studying the effects of a tobacco sales ban in supermarkets on youth and adults from disadvantaged neighborhoods.  

Nicola Lindson is the lead of the Oxford Tobacco Addiction Group in the Centre for Evidence Based Medicine, Nuffield Department of Primary Care Health Sciences (NDPCHS), University of Oxford. She received her PhD in Behavioural Medicine from the University of Birmingham in 2012. Her research mainly focuses on the efficacy and safety of treatment for tobacco smoking, in particular in population groups with higher smoking prevalence rates, such as people experiencing financial difficulty, living in social housing and experiencing serious mental health issues. She has particular expertise in systematic reviewing and randomised controlled trials. She also contributes to teaching both the undergraduate and postgraduate curriculum at the University of Oxford, and is a Fellow of Kellogg College, University of Oxford.

Felix is a Professor of Health Psychology within the School of Health Sciences, University of East Anglia, Visiting Senior Researcher at the Behavioural Science Group, University of Cambridge, and Honorary Associate Professor within the Division of Primary Care, University of Nottingham. He has a key research interest in the development and evaluation of mobile phone interventions to promote and support health behaviour change (mHealth), particularly smoking cessation.